Both studies identify the circulating protein growth differentiation factor 11 (GDF11), a member of the transforming growth factor-β (TGF-β) family, as being at least one of the agents ...

Researchers from the Harvard Stem Cell Institute (HSCI) have shown that injections of a protein dubbed GDF11, when administered to older mice, appear to cause a reversal of many signs of aging.

Elevian is one of several companies searching for ways to increase life span — in this case, using a protein called GDF11. But challenges lie ahead. By Eilene Zimmerman This article is part of ...

Two studies, both in Science, focused on a protein called GDF11, which, in its mature form, is identical in mice and humans, Wagers said. “By boosting the levels of GDF11, we could, in mice ...

In two separate articles scientists report that injections of a protein known as GDF11, which is found in humans as well as mice, improved the exercise capability of mice equivalent in age to that ...

The scientists found that levels of a protein called GDF11 decreased in the blood of mice as they grew older. When the researchers injected the protein into the heart muscle of old mice ...

Update 3/26/2019: In 2017, a small clinical trial that involved injecting plasma from young people into Alzheimer’s patients found extremely limited benefits. For more information on the young ...

Elevian was launched two years ago with $5.5 million in backing to develop drugs based on GDF11 (growth differentiation factor 11), a Harvard University-discovered protein it says is linked to age ...

Rubin and Wagers each said that, baring unexpected developments, they expect to have GDF11 in initial human clinical trials within three to five years. Postdoctoral fellow Lida Katsimpardi is the lead ...

Rubin and Wagers each said that, baring unexpected developments, they expect to have GDF11 in initial human clinical trials within three to five years. Postdoctoral fellow Lida Katsimpardi is the lead ...